An AI/ML/Genomics specialist developing AI tools such as BioMYND, BioSport, PanOmiQ, BioEMR for diagnosis & treatment and remote monitoring of patients.
BioAro is a Calgary-based biotech delivering AI-powered precision health platforms to accelerate diagnostics, drug discovery, and personalized medicine. Key Products PanOmiQ: Real-time multi-omics engine for ultrafast Genomics, Transcriptomics, Epigenomics, Microbiome sequencing (under 5 minutes) for disease risk & prediction and Pharmacogenomics. PanAUM: Unified AI platform integrating genomics, proteomics, and epigenomics for target identification, toxicity modeling, and patient stratification in pharma R&D. Genelio: Consumer facing Longevity & Wellness AI-platform for translating DNA data into actionable plans for longevity and performance optimization. BioMYND: AI-driven platform focused on brain and emotional health, built on the same AI and multi-omics foundation as PanOmiQ. It combines cognitive well, facial/emotion recognition, IoT device data, and genomic insights to detect early cognitive decline, monitor mental wellness, and deliver personalized cognitive training and stress management recommendations. Its poistioned for partners in neurodegeneration, mental health, digital therapeutics, and aging, offering a platform for early detection (for example Alzheimer’s and Parkinson’s risk), remote monitoring, and AI-driven interventions that bridge cardiometabolic and brain health It has two Point of Care Diagnostic devices on the market (FDA & Health Canada approved) which include a 24/7 Ambulatory Blood Presure and ECG Monitoring (Holter) devices. A next generation cuffles Blood pressure, ECG, Heart Rate and Oxygen saturation measuring device is currently undergoing clinical trials. Target Audience at Swiss Biotech Days BioAro seeks partnerships with Swiss and European Pharma drug developers, Biotech startups, mid-sized firms, CROs (Contract Research Organizations), and investors focused on AI-biotech integration. Perfect for Global Village delegations interested in cross-border R&D collaborations, data analytics tools, and launches into North American tech commercialization.
Raja has expertise in Research #Innovation, #TechnologyCommercialization & Translational research. Working with entrepreneurs, investors, KOL, policy makers and technology developers, these efforts have led to creation of several large scale Provincial initiatives, pan-Canadian Academic consortia and Start-up companies. With a focus on translation and adoption of novel cutting-edge innovation into the market, Raja has supported the creation of significant infrastructure for early stage development, validation & translation of POC diagnostic devices, Artificial intelligence/Machine learning, Genomics, Precision Health & Personalized medicine.